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Autologous neutralizing antibody responses of 
nontransmitting and transmitting mothers. IC50s 
of nontransmitting and transmitting mothers are 
color coded by mother. Each square or dot 
represents the IC50 of an individual envelope 
variant tested against contemporaneous 
autologous plasma. Data are shown as raw 
IC50s on a log2 scale  higher Log2IC50 suggests 
a more neutralization-sensitive virus variant; 
black bars represent medians and IQRs, and the 
dotted line represents an IC50 of 25 (resistant to 
neutralization at a 1:50 dilution). 
 
Figure provided by Caitlin Milligan. 
 
As of June 30th of last year, the fight against HIV reached another milestone: Cuba became the first 
country where HIV mother-to-child transmission (MTCT) was declared eliminated. While we expect 
other countries to reach the same milestone soon, we are aware that in many realities, achieving this 
goal will require more work and resources. In fact, although it has been demonstrated that a large 
proportion of MTCT occurs during breastfeeding, not every country has the ability to ensure that 
infected mothers have access to potable water and breast milk substitutes. In these situations, 
effective strategies to avoid transmission are still sought.  
Evidence obtained from human and non-human primate studies suggests that neutralizing 
antibodies (NAbs), which inhibit viral infection, might play a role in decreasing HIV MTCT. Consistent 
with this, infants are usually infected with a single virus variant, one that is in general more resistant 
to neutralization than other maternal virus variants. Therefore, it is possible that maternal 
transmission risk correlates with a higher frequency of neutralization-resistant viruses.  
To test this hypothesis, Caitlin Milligan and others from the Overbaugh Laboratory (Public Health 
Sciences and Human Biology Divisions) at Fred Hutch compared the viral populations of HIV 
transmitting and nontransmitting mothers for their sensitivity to neutralizing antibodies.  The samples 
for the study were collected in the mid-1990s before antiretroviral therapies to prevent MTCT were 
available. The results of the study were recently published in the journal MBio. 
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The cohorts were chosen in order to achieve a clear answer: only breastfeeding mothers with high 
viral loads (thus higher probability of transmitting HIV), whose newborn children were HIV negative 
at birth were selected for the study. Moreover, the HIV status of children was monitored regularly to 
precisely determine the time of infection. The study tested maternal antibody and envelope (Env) 
variants at a time point shortly before seroconversion of the children. For each mother, five different 
clones encoding for Env were tested for sensitivity to neutralization by paired maternal plasma. 
Viruses carrying Envs cloned from transmitting and non-transmitting mothers showed a range of 
neutralization sensitivities (as shown in the figure). The overall sensitivities were comparable in the 
two groups when the most concentrated plasma dilutions were used, while when lower dilutions, 
comparable to those demonstrated to protect against infection in non-human primates, were tested, 
non-transmitting mothers unexpectedly had higher percentages of neutralization-resistant viruses. 
This study shows that both nontransmitting and transmitting mothers have neutralization-resistant 
viruses, suggesting that the presence of these viruses alone does not predict transmission risk. 
"These results suggest that HIV mother-to-child transmission in the early breastfeeding period is not 
solely due to the presence of neutralization resistant viruses and likely involves multiple factors", 
said Milligan. Identification of other factors associated with the risk of MTCT may help elucidate 
mechanisms that can be targeted to prevent transmission and infection in other populations. 
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